Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rodgers

Showing results (41-50 of 440) with videos related to

Pageof 44
Sort By:
Seminars in Hematology|October 18, 2001
Pathophysiology of sickle cell disease: role of cellular and genetic modifiersM H Steinberg, G P Rodgers
JAMA|September 9, 2020
Obesity and Hypertension in the Time of COVID-19Griffin P Rodgers, Gary H Gibbons
Annals of Internal Medicine|January 6, 2017
Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag BehindJudith E Fradkin, Griffin P Rodgers
JAMA|October 10, 1986
Amniotic fluid embolismG P Rodgers, G J Heymach
Clinical Radiology|June 21, 2006
Pseudomembranous colitis revisited: spectrum of imaging findingsI Ramachandran, R Sinha, P Rodgers
Analytical Chemistry|May 3, 2011
Petroleum analysisRyan P Rodgers, Amy M McKenna
British Journal of Haematology|December 19, 1998
Activation of the human delta-globin gene promoter in primary adult erythroid cellsD C Tang, G P Rodgers
The New England Journal of Medicine|May 18, 1995
Sickle cell anemia--basic research reaches the clinicA N Schechter, G P Rodgers
Experimental Hematology|August 17, 2004
Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell lineOlga P Zoueva, Griffin P Rodgers
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2008
Petroleomics: chemistry of the underworldAlan G Marshall, Ryan P Rodgers
Pageof 44

Showing results (41-50 of 440) with videos related to

Sort By:
Pageof 44
Seminars in Hematology|October 18, 2001
Pathophysiology of sickle cell disease: role of cellular and genetic modifiersM H Steinberg, G P Rodgers
JAMA|September 9, 2020
Obesity and Hypertension in the Time of COVID-19Griffin P Rodgers, Gary H Gibbons
Annals of Internal Medicine|January 6, 2017
Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag BehindJudith E Fradkin, Griffin P Rodgers
JAMA|October 10, 1986
Amniotic fluid embolismG P Rodgers, G J Heymach
Clinical Radiology|June 21, 2006
Pseudomembranous colitis revisited: spectrum of imaging findingsI Ramachandran, R Sinha, P Rodgers
Analytical Chemistry|May 3, 2011
Petroleum analysisRyan P Rodgers, Amy M McKenna
British Journal of Haematology|December 19, 1998
Activation of the human delta-globin gene promoter in primary adult erythroid cellsD C Tang, G P Rodgers
The New England Journal of Medicine|May 18, 1995
Sickle cell anemia--basic research reaches the clinicA N Schechter, G P Rodgers
Experimental Hematology|August 17, 2004
Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell lineOlga P Zoueva, Griffin P Rodgers
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2008
Petroleomics: chemistry of the underworldAlan G Marshall, Ryan P Rodgers
Pageof 44